Venus Concept, Inc. is a global medical technology company, which engages in the business of developing, commercializing, and selling minimally invasive and non-invasive medical aesthetic and hair restoration technologies. The company is headquartered in Toronto, Ontario and currently employs 292 full-time employees. The company went IPO on 2017-10-12. The firm develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Follow-Up Questions
Venus Concept Inc의 CEO는 누구입니까?
Mr. Rajiv De Silva은 2022부터 회사에 합류한 Venus Concept Inc의 Chief Executive Officer입니다.
VERO 주식의 가격 성능은 어떻습니까?
VERO의 현재 가격은 $2.28이며, 전 거래일에 decreased 0.65% 하였습니다.
Venus Concept Inc의 주요 사업 주제나 업종은 무엇입니까?
Venus Concept Inc은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Venus Concept Inc의 시가총액은 얼마입니까?
Venus Concept Inc의 현재 시가총액은 $4.2M입니다
Venus Concept Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 3명의 분석가가 Venus Concept Inc에 대한 분석 평가를 실시했으며, 이는 0명의 강력한 매수, 0명의 매수, 4명의 보유, 1명의 매도, 그리고 0명의 강력한 매도를 포함합니다
